Back to discover

Protein / target

Protein S100-G

Encoded byS100GP29377Homo sapiensSwiss-Prot
Degrader-tractable
Druggability
Database Ubiquitination
1
Research papers

Protein at a glance

Biological role

Calcium-dependent protein binding

Strongest disease association

Colitis

Via encoding gene S100G · Literature evidence · score 0.02

Research activity

Emerging research

1 papers · latest 1995

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Domains and Gene Ontology detail (9)

Domains & features

EF-hand 1EF-hand 2

Gene Ontology

  • Capical plasma membrane
  • Cbasolateral plasma membrane
  • Ccytoplasm
  • Fcalcium ion binding
  • Fcalcium-dependent protein binding
  • Ftransition metal ion binding
  • Fvitamin D binding

79 aa · 9 kDa

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene S100G

Gene-level evidence surfaced through the gene S100G that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Colitis
0.02Preliminary

Literature evidence dominant · Open Targets 0.02 · no direct causal or clinical evidence

Liver Neoplasms
0.02Preliminary

Literature evidence dominant · Open Targets 0.01 · no direct causal or clinical evidence

Neurodegenerative Diseases
0.02Preliminary

Literature evidence dominant · Open Targets 0.01 · no direct causal or clinical evidence

Rectal Neoplasms
0.01Preliminary

Literature evidence dominant · Open Targets 0.01 · no direct causal or clinical evidence

Diabetes Mellitus, Type 1
0.01Preliminary

Literature evidence dominant · Open Targets 0.01 · no direct causal or clinical evidence

View evidence synthesis (5)
ColitisPreliminary
0.02
agreement 0.000.29
Literature100%

Open Targets aggregate 0.02 · 1 independent evidence family · no direct causal or clinical evidence

Liver NeoplasmsPreliminary
0.02
agreement 0.000.29
Literature100%

Open Targets aggregate 0.01 · 1 independent evidence family · no direct causal or clinical evidence

Neurodegenerative DiseasesPreliminary
0.02
agreement 0.000.29
Literature100%

Open Targets aggregate 0.01 · 1 independent evidence family · no direct causal or clinical evidence

Rectal NeoplasmsPreliminary
0.01
agreement 0.000.29
Literature100%

Open Targets aggregate 0.01 · 1 independent evidence family · no direct causal or clinical evidence

Diabetes Mellitus, Type 1Preliminary
0.01
agreement 0.000.29
Literature100%

Open Targets aggregate 0.01 · 1 independent evidence family · no direct causal or clinical evidence

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Colitis0.02
Liver Neoplasms0.01
Neurodegenerative Diseases0.01
Rectal Neoplasms0.01
Diabetes Mellitus, Type 10.01
Neoplasms0.01

Tractability

Protein degradersEmerging

Feasibility evidence (database ubiquitination) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (1)
PR · Database Ubiquitination

Raw Open Targets tractability assessment buckets, by modality.

Research activity

1 papers · to 1995

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Sik A · The Journal of neuroscience : the official journal of the Society for Neuroscience · 1995

Recent

Hippocampal CA1 interneurons: an in vivo intracellular labeling study.

Sik A · The Journal of neuroscience : the official journal of the Society for Neuroscience · 1995

Europe PMC papers linked directly to this protein.